wian children with severe malaria to identify the prevalence and common causative organisms of bacteremia and to examine risk factors for bacteremia and death, including HIV infection.
SUBJECTS, MATERIALS, AND METHODS
Study site and study population. We examined data from children admitted to the Paediatric Research Ward at the Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi, during the rainy season (mid-December to mid-June) each year from 1996 through 2005. QECH is the district hospital for Blantyre District and admits children with severe malaria after primary presentation or secondary referral from urban and rural health centers. QECH is also a tertiary referral hospital for the southern region of Malawi, but such referrals rarely include severe malaria because these are cared for at the district hospital level. We admit children у6 months old who are comatose or severely anemic, regardless of the presence or absence of Plasmodium falciparum parasites on peripheral-blood film. Not all children with severe malaria in the pediatric wards at QECH are admitted to the research ward, and the pattern of admissions to studies of severe malaria reflects the research emphasis on CM.
A final diagnosis of 1 of 3 severe malaria syndromes-CM, SMA, or CM with SMA (CM+SMA)-is established as follows. CM is defined as asexual P. falciparum parasites present on a peripheral-blood film for a patient with a Blantyre coma score (BCS) of 2 or less persisting for 12 h after other identifiable causes of coma (such as hypoglycemia, postictal state, and meningitis) have been excluded. SMA is defined as asexual P. falciparum parasites present on a peripheral-blood film for a patient with a BCS of 3 or higher and with either (1) a packed red cell volume (PCV) of 10% or less, (2) a PCV of 11%-15% with evidence of clinical decompensation (obtundation, respiratory distress, or heart failure), or (3) a PCV of 115% with the requirement of a blood transfusion on clinical grounds. CM+SMA is defined as occurring in any patient who meets the definition of CM and who additionally has a PCV of 15% or less or who requires a blood transfusion.
Clinical management and investigations. All children admitted to the ward undergo a complete, standardized history and physical examination. Blood glucose and lactate concentrations, peripheral parasite density, and PCV are measured on admission and every 6 h thereafter. A white blood cell count (WCC) and a single blood sample for culture are obtained on admission, and blood culture is repeated later during the illness if clinically indicated. A lumbar puncture is done on admission, unless there is a contraindication, for all patients with a BCS of 2 or less and for any other patient whose clinical presentation warrants it; opening pressure, cell count, and culture results are recorded. After diagnosis, children are managed according to standard protocols. Children with meningitis or with evidence (from data collected on admission) of a second diagnosis that overlaps symptomatically with malaria were excluded from this analysis.
All of the study children were treated with intravenous quinine, with a loading dose of 20 mg/kg given over 4 h, followed by 10 mg/kg every 12 h for at least 24 h and then by a single dose of sulfadoxine-pyrimethamine. A blood transfusion was given if a child had a PCV of !12% or was in respiratory distress or coma associated with severe anemia.
Antibiotics were administered to patients on the basis of clinical suspicion of bacteremia or septicemia either on admission (e.g., low blood pressure, cool peripheries, or severe respiratory distress) or later during the course of the disease (e.g., persistence of fever after malarial parasites had cleared). Antibiotics were given parenterally according to blood culture susceptibility results or, when given presumptively, according to recommendations for first-line antibiotics for suspected septicemia in children at QECH at the time-chloramphenicol either with or without gentamicin. The choice and duration of antibiotic were reconsidered when the blood culture and antibiotic susceptibility results were known. At the time of discharge, all children were classified as having either made a full recovery, survived with neurological sequelae, or died.
Laboratory methods. Blood was obtained for culture by standard methods and was investigated in the microbiology laboratory of the Malawi-Liverpool-Wellcome Trust Clinical Research Programme in Blantyre, as described elsewhere [5, 6] . One milliliter of venous blood was added to 20 mL of brainheart infusion broth containing sodium polyanethol sulphonate (E&O Laboratories). Cultures were examined macroscopically every day and were Gram stained if turbid or hemolysed. Subcultures and direct susceptibility testing were done as directed by the Gram-stain findings. All samples were subcultured on sheep blood agar after 18-24 h, 36-48 h, and 7 days. All plates were incubated in a candle jar and examined after 24 and 48 h of incubation. Isolates were identified according to standard techniques [10] . Antibiotic susceptibilities were determined by disk diffusion, interpreted until 2001 using the National Committee for Clinical Laboratory Standards guidelines [11] and from 2001 using the British Society for Antimicrobial Chemotherapy guidelines [12] . Mixed growths or growth of micrococci, Bacillus species, or coagulase-negative staphylococci were considered to be contaminants, and patients with such results were considered to be uninfected in the analysis.
From 2001 through 2005, the parent or guardian of every patient was precounseled for HIV testing. If a guardian accepted, HIV testing was done using 2 rapid tests for HIV-1 and HIV-2, Uni-Gold (Trinity Biotech) and Determine (Abbott Laboratories). If the results were discrepant, a tiebreaker test was performed using the Capillus rapid test (Trinity Biotech). The results were provided to the patient/guardian, if they de- variables that have been previously described as being independent risk factors for the outcome of interest as well as on all variables considered to be potential risk factors, confounding variables, or effect modifiers. Multivariate logistic regression models were developed using both forward and backward stepwise approaches. All models were assessed with the Hosmer and Lemeshow goodness-of-fit test; no evidence of lack of fit was identified (x 2 for each model). 
RESULTS
Bacteremia and severe malaria. From 1996 through 2005, we admitted 1791 patients who met research ward enrollment criteria (figure 1). Of these, 1388 met the study case definitions and had available blood culture results: 774 with CM, 171 with SMA, and 443 with CM+SMA (table 1) . Sixty-four (4.6% [95% confidence interval {CI}, 3.6%-5.9%]) had a positive blood culture, and NTS accounted for the majority (58%) of the positive blood cultures. Other common isolates were Streptococcus pneumoniae (11%) and enteric gram-negative rods (20%). The patients with bacteremia differed from those without bacteremia; they were significantly younger, more anemic, and had a higher WCC on admission (table 2). The patients with bacteremia were not significantly more likely to be HIV infected than those without bacteremia. Both all-cause bacter- ). The HIV-infected children had signif-P p .61 icantly lower PCVs on admission, lower weight-for-age z scores, and a higher prevalence of NTS bacteremia than did the HIVuninfected children (table 4). The case-fatality rate was similar for the 2 groups.
Risk factors for bacteremia and death. Risk factors for bacteremia and NTS bacteremia differed between the SMA group and the CM/CM+SMA groups (tables 5 and 6). The CM and CM+SMA groups are presented together because for each outcome the risk factors were similar when the 2 groups were analyzed separately. In the SMA group, the risk factors for bacteremia included HIV infection, obtundation, deep breathing, and a history of having received traditional medicine for the current illness. HIV infection was a risk factor for both bacteremia and NTS bacteremia in the SMA group but was not associated with either in the CM/CM+SMA group. The highest case-fatality rate was in the CM+SMA group (table 3) . The risk factors for death in the children with SMA and with CM or CM+SMA are listed in tables 5 and 6, respectively. Bacteremia and NTS bacteremia were not associated with death in either group. Table 7 indicates when and why antibiotics were initiated; the administration of antibiotics was not associated with outcome ( , for the CM+SMA group; , for the SMA P p .31 P p .92 group). Results of susceptibility testing were available for 42 of the 44 children with bacteremia who received antibiotics. Of these, 40 (95%) were given an antibiotic to which their organism was susceptible; 2 did not receive an appropriate antibiotic but recovered fully. Twenty children with bacteremia did not receive antibiotics; 6 died on admission and 9 had culture results returned after the patient was discharged, and in 3 cases the timing of the culture result is unknown. The other 2 children died before blood culture results were available; one died 6 h after admission, and the other was admitted with CM+SMA and, although there was resolution of coma, died suddenly while receiving a blood transfusion 29 h after admission. Six patients with bacteremia who received antibiotics died; in each case, septicemia was suspected on clinical grounds, and antibiotics to which the organism was later found to be susceptible were initiated on admission. 
DISCUSSION
We found a significant difference in the prevalence and pattern of bacteremia between groups of African children with different clinical presentations of severe malaria. Previous prospective studies of bacteremia in African children with severe malaria mainly included patients with CM and found a similar prevalence of bacteremia caused by a wide range of gram-positive and gram-negative organisms, as was found in patients with CM or CM+SMA in the present study [1, 2] . In studies of childhood bacteremia in the region, NTS bacteremia has been significantly associated with severe anemia and with malaria compared with other common causes of childhood bacteremia [3] [4] [5] [6] [7] . Consistent with the results implied in these earlier studies, the present study is the first prospective study to show that NTS bacteremia is associated with SMA.
NTS pathogens were the most common isolate on blood culture in Ghanaian children who remained febrile after clearance of malarial parasitemia and in Malawian children after blood transfusion for SMA [13, 14] . In Malawian children with NTS bacteremia, blood for culture was obtained significantly later from those who had malaria parasitemia on admission [6] . It was not clear from these studies whether NTS bacteremia occurred as a complication after treatment for malaria or whether coinfection was present on admission and a positive malaria slide on admission had delayed the diagnosis of bacteremia. We have shown that NTS pathogens were the cause of 73% of bacteremias in children with SMA with or without CM and that NTS bacteremia was present at the time of admission. This has implications for use of antibiotics in children with SMA.
Young age and malnutrition may confound the association between NTS bacteremia and SMA. NTS bacteremia most commonly presents in children who are !2 years of age and malnourished [6] . SMA typically presents at a younger age than does CM-as was found in the present study (table 3)-and malnourished children have a significantly higher frequency of bacteremia, including NTS bacteremia, than do those with normal nutrition [15] . We found that severe anemia remained a significant risk for NTS bacteremia independent of age, malnutrition, and level of coma. This is the first study to describe the prevalence of HIV infection and its impact on bacteremia in a large number of children with severe malaria. In an earlier study [16] , the HIV prevalence among children admitted to QECH with severe malaria was 13%, similar to that found in the present study. Most cases of NTS bacteremia in African adults are HIV related [17, 18] ; however, in contrast, the association between NTS bacteremia and severe anemia in African children was described when childhood HIV prevalence rates were zero or still very low [3, 4, 19, 20] . Studies from the region report that the majority of children with NTS bacteremia are not HIV infected even though bacteremia, including NTS bacteremia, is significantly more common in HIV-infected children [7, 8, 21, 22] . We also found that the majority of children with bacteremia and severe malaria were not HIV infected but that HIV infection was a significant risk factor for bacteremia in those with SMA.
We found that HIV-infected children with severe malaria were significantly older and more anemic than HIV-uninfected children. Young age was associated with NTS bacteremia in those with SMA, but HIV infection was a significant risk factor for bacteremia in the SMA group independent of age. Anemia and malnutrition were associated with NTS bacteremia in those with CM or CM+SMA, but HIV infection was not a significant risk factor for bacteremia in this group.
Other independent risk factors for bacteremia in children with SMA were deep breathing and obtundation. It may be that these features represent general clinical decompensation due to severe anemia and that these children are, therefore, more vulnerable to bacterial invasion, or it may be that an existing bacteremia contributes to obtundation and deep breathing due to acidosis. A history of having received traditional medicine for the presenting illness was also associated with an increased risk of bacteremia in children with SMA. Traditional medicine given orally is commonly used in Malawian children and characteristically causes metabolic acidosis, gastric bleeding, and intestinal ileus that can be fatal. It is possible that traditional medicine facilitates the entry of bacterial pathogens from the gut into the bloodstream. Alternatively, seeking treatment from traditional healers may delay presentation to a hospital.
The case-fatality rate was higher in the 64 children with severe malaria and bacteremia (21.8%) than in those without bacteremia (16.0%), but the difference was not significant. The case-fatality rate was higher for HIV-infected children than for HIV-uninfected children, but the difference was not significant-even in those with SMA, in whom bacteremia was significantly more common in HIV-infected children. On multivariate analysis, the risk factors for death were clinical features that have been previously described as indicators of poor prognosis in children with severe malaria, such as hypoglycemia, degree of coma, and deep breathing [23, 24 ] . A lower BCS in children with SMA and a higher WCC in those with CM or CM+SMA were independent risk factors for both bacteremia and death.
Should parenteral antibiotics be given routinely to all children with severe malaria? Our data do not provide support for such a recommendation but rather highlight the contributions of a number of important clinical variables to the occurrence of bacteremia and to malaria-related mortality. Routine parenteral antibiotics may not improve outcome among children with severe malaria if such children are dying with bacteremia but not because of bacteremia. In earlier studies of children with severe malaria, it was noted that many children with bacteremia improved without antibiotics [1, 2] . In our study, poor outcome was associated with previously described indicators of poor prognosis in severe malaria but not significantly with bacteremia, although the contribution of bacteremia to some of these features, such as anemia, deep breathing, and hypoglycemia, is unclear. The use of antibiotics was not associated with a better outcome, but the present study was not designed to assess the benefit of antibiotics. All but one of the children with bacteremia who died were either given antibiotics on admission or died within hours of admission, before antibiotics would have been likely to make an impact.
We have shown that NTS bacteremia is common in children with SMA. Presumptive use of antibiotics that are effective against NTS in children with SMA may not have a significant immediate impact on malaria-related mortality but might provide benefit in the prevention of focal disease (such as meningitis) that may follow NTS bacteremia, particularly in young children [25] [26] [27] . NTS is a common cause of meningitis in Malawian children !2 years of age, and prevalence is highest during the few months after the peak malaria season [28] . In a study of bacterial meningitis at QECH [29] , 9 (31%) of 29 patients with NTS meningitis had a history of recent blood transfusion for severe anemia, compared with 10 (1.8%) of 568 patients with other causes of bacterial meningitis ( ; P ! .00001 E. M. Molyneux [Department of Paediatrics, University of Malawi College of Medicine], unpublished data). A recent study in Malawi has found high postdischarge mortality in children treated in hospital for severe anemia and then followed for 6 months (M. B. van Hensbroek [Malawi-Liverpool-Wellcome Trust Clinical Research Programme], unpublished data). NTS bacteremia is being investigated as one possible cause for this postdischarge mortality; if it is found to be the cause, then the potential benefit of routine antibiotics in children with SMA should be further investigated.
There are several limitations to the present study. Some associations in the regression models may not have reached statistical significance because of the small sample size, particularly in the SMA group. Home treatment before admission with medicines having antibiotic activity could have reduced the number of positive blood cultures detected on admission and confounded our observations; however, there was no difference in the frequency of reported home treatment between the children with bacteremia and those without (table 2). It is also possible that a robust organism such as NTS is more likely to be isolated than more fastidious ones; however, culture techniques were consistent across groups, such that this should not have biased the comparisons between groups.
This study provides data to guide antibiotic use in the management of severe malaria in settings in which HIV is endemic. Routine antibiotic therapy is not indicated in children with CM. If septicemia is suspected on admission or at any later stage of management in children with SMA, with or without altered consciousness, initial antibiotic therapy should be aimed at locally prevalent NTS. The potential of routine antibiotics in reducing early and late mortality in children with SMA requires further investigation.
